Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
COVID-19 Vaccine
32 Articles Available
0
2
Can't find what you're looking for? Try our
advanced search
.
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
PAO-10-23-CL-07
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
PAO-04-022-CL-02
Column: Technology
mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?
PAO-03-022-NI-02
COVID-19 Vaccines
Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?
PAO-03-022-NI-05
COVID-19 Vaccines
The Global Immunization Disparity
PAO-02-022-CL-04
COVID-19 Vaccine
AGC Biologics Supports Omicron-Based Vaccine Candidate Manufacturing with Starting Material
PR-M02-22-07
COVID-19 Vaccine
FDA Approves SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine
PR-M02-22-01
Thermal Packaging
With Omicron Variant on the Rise, Thermal Custom Packaging (TCP) is Providing Secure Transportation of COVID Vaccine
PR-M01-22-02
Collaboration
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
PR-M12-21-02
Viral Vaccines
Viral Vectors, Vaccines — A New Era Of Collaborative Design
PAO-10-21-CL-17
Gene Therapy
Pandemic Playbook for Gene Therapy Manufacturing
PAO-09-21-CL-14
COVID-19 Vaccine
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial
PR-M06-21-028
Cleanrooms
Rapid Cleanroom Builds for COVID-19 Facilities: Lessons Learned
PAO-06-21-CL-06
Genetic Vaccines
Working to Overcome Analytical Challenges Posed by Genetic Vaccines
PAO-06-21-NI-01
COVID-19
Preparing for the Next Pandemic: Lessons Learned from COVID-19
PAO-06-21-CL-01
COVID-19 Vaccine
Pfizer and BioNTech to Vaccinate Olympic Athletes in Tokyo
PR-M05-21-014
COVID-19 Vaccine
Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial
PR-M05-21-011
Vaccines
A Look at Genetic Vaccine Development and Manufacturing
PAO-05-21-NI-03
COVID-19 Vaccines
The COVID-19 Vaccine Journey Continues
PAO-05-21-NI-02
Emergency Use
Pfizer and BioNtech Receive First U.S. Authorization for Emergency Use of Covid-19 Vaccine in Adolescents
PR-M05-21-007
COVID-19 Vaccine
iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program
PR-M05-21-005
COVID-19 Vaccine
EMA Starts Evaluating Use of COVID-19 Vaccine Comirnaty in Young People Aged 12 to 15
PR-M05-21-005
COVID-19
Moderna Announces Supply Agreement with Gavi for up to 500 Million Doses of COVID-19 Vaccine Moderna for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries
PR-M05-21-002
COVID-19 Vaccine
Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine
PR-M05-21-001
«
0
2
»
.svg)
